RESUMO
BACKGROUND: Rice has been used for cosmetic purposes for centuries and its benefits have been translated into modern-day skin careproducts. METHODS: Pubmed and google were searched with the terms "skin care" and "cosmetics" in conjunction with the words "rice", "rice bran", and "fermented rice bran". Resulting articles were analysed for potential benefits of ingredients contained within rice for skin care and summarised. RESULTS: Individual components of rice have been identified including phenolic compounds, betaine, squalene, tricin, and rice bran. These rice-derived ingredients have been found to be antiaging, anti-inflammatory, whitening, photoprotective, and moisturizing. Moreover, rice-derived ingredients have demonstrated benefits for dermatological conditions. Rice bran ash extract increases melanin synthesis and offers protection from radiation and skin injury. Fermented rice bran extract and rice bran broth baths have shown utility in atopic dermatitis treatments. Literature suggests that rice-derived ingredients are also safe, non-irritating, and hypoallergenic. CONCLUSION: Ingredients isolated from rice and its components have wide potential for use in skin care and cosmetic products.
Assuntos
Dermatite Atópica , Oryza , Humanos , Dermatite Atópica/terapia , Pele , Extratos Vegetais/farmacologiaAssuntos
Miocardite , Tifo Endêmico Transmitido por Pulgas , Animais , Febre , Humanos , Camundongos , Miocardite/diagnóstico , Miocardite/etiologia , Tifo Endêmico Transmitido por Pulgas/complicações , Tifo Endêmico Transmitido por Pulgas/diagnóstico , Tifo Endêmico Transmitido por Pulgas/tratamento farmacológicoRESUMO
Since the publication of our previous paper, Visual cycle proteins: Structure, function, and roles in human retinal disease (Tsin, et.al, JBC 293:13016, 2018) there has been significant progress on multiple topics discussed in this paper. In the present communication, we further explore research advances on two visual cycle proteins: DES1 and IRBP. In addition, we emphasize the progress of clinical translation of other visual cycle protein research, including the breakthrough of FDA-approved gene therapy for Leber's congenital amaurosis, and additional gene therapies at different stages of clinical trials for various retinal diseases such as retinitis pigmentosa, diabetic retinopathy, and Stargardt's disease.